Goldman sells final stake in former independent-research partner
NEW YORK, March 15 (Reuters) - Goldman Sachs Group Inc received $32.5 million for its remaining stake in Epocrates Inc, after the healthcare technology company was acquired by athenahealth Inc, according to a securities filing on Friday.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here